With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
29th April 2026 Uncategorised 0While Teva Pharmaceutical’s multiyear growth streak under CEO Richard Francis showed signs of leveling off, the company still topped Wall Street estimates in 2026’s first quarter, buoyed by the impressive performance of branded drugs like Austedo, Uzedy and Ajovy.
More: With Austedo at helm, Teva's impressive innovative drug sales signal company's successful metamorphosis
Source: fierce
